Management to Host Conference Call Today at 4:30 p.m. ET
SANTA FE, NM / ACCESSWIRE / April 26, 2022 / Sigma Labs, Inc. (NASDAQ:SGLB) (the "Company" or "Sigma Labs"), a leading developer of quality assurance software to the commercial 3D printing industry, has reported its financial and operational results for the first quarter ended March 31, 2022.
"The first quarter of 2022 is the beginning of a new era for Sigma Labs. An era in which we move from one off project sales, to one that we believe is accessible at scale for supporting qualification and production across thousands of machines at hundreds of customer sites," commented Jacob Brunsberg, Sigma's President, and Chief Executive Officer. "This transition will not happen overnight but is being accelerated faster than we anticipated. In fact, we began to broadly market under our new subscription model during the first quarter, continue to grow our pipeline, and closed our first subscription sale."
Key First Quarter 2022 Highlights and Business Update
- Appointed Jacob Brunsberg Chief Executive Officer of Sigma Labs, effective April 1st. Mark Ruport, Sigma Labs' former Chief Executive Officer transitioned to the role of Chairman of the Board of Directors.
- Announced that the Company was developing product to cover the full spectrum of in-process quality and continuing to position its technology to transition from R&D to full scale production, putting Sigma Labs in position to address the needs of thousands of machines.
- Announced a concurrent change in Sigma Labs' business model that the Company believes will enable distribution at scale for a high margin, software-only in-situ quality monitoring and analytics solution.
- Sigma Labs' new subscription-based pricing model improves the economics of 3D printing, lowers the barriers of entry for customers, and allows for faster technology adoption and expansion, while producing more consistent and predictable cash flow for the Company.
- Continued to expand its partner ecosystem and distribution network, announcing worldwide agreements with printer manufacturer Aconity3D, with AMFG, a software manufacturing execution system (MES) company, and appointed Phillips Federal as its exclusive reseller to the U.S. Federal Government.
- Collaborated with Materialise to develop closed loop capabilities geared towards enhancing the scalability of metal AM applications by combining the Materialise Control Platform and Sigma Labs' PrintRite3D® sensor technology to allow users to identify and correct metal build issues in real-time.
- Continued to lead in quality standards with Sigma Labs becoming a founding member of an ASTM consortium and announced that its PrintRite3D® in-process quality assurance solution was acquired by Auburn University to support several projects at the National Center for Additive Manufacturing Excellence (NCAME) to improve commercial air and space travel under grants from NASA and the FAA.
Management Commentary
Mr. Brunsberg continued, "We intend to set the quality standard for the industry by collaborating and supporting industry participants, from the most successful, to the new, up and coming 3D printer manufacturers, and integrating with additive manufacturing software solution providers. Through this effort, our goal is to dramatically lower the barriers to entry for the additive manufacturing industry and enable end users to expand their use of industrial 3D printing at a lower cost with higher quality results."
"We are also developing exciting new products that will combine streaming machine health data from major OEMs, off-axis camera data, and on-axis meltpool technology to provide a centralized home for all industry in-process quality solutions. We believe the connected data will allow users to simplify their quality operations, identify gross defects, utilize our machine learning and AI platform, and improve the total cost of development and production."
"Our collaboration with long-term partner Materialise has resulted in a technology platform that delivers an industry-first ability to identify and address process and quality issues in real time. We believe this dramatically improves the productivity in metal AM and reduces scrap rates, paving the way for manufacturers to advance their operations and increase the implementation of metal AM in serial production," continued Brunsberg.
"Jacob has set a plan in place that leverages Sigma's core competency, removes significant barriers of entry for the Company, as well as the end users, and has created a sense of urgency in developing relationships with industry stakeholders including OEMs, additive software companies, material providers, and post-processing technologies," stated Mark K. Ruport, Chairman of Sigma Labs. "We believe it will be an exciting year for Sigma and the entire industry," he added.
"Looking ahead, we continue to migrate to our software only model which we believe will deliver more value to our customers, increase our ability to address the total market, including the large polymer sector, and allow for greater adoption yielding increased margins on our products. As a company, we are expanding our depth and reach with new partnerships that we believe will drive Sigma Labs' growth as well as our industry. I look forward to providing additional updates in the months to come on our progress," concluded Brunsberg.
First Quarter 2022 Financial Results
Revenue for the first quarter of 2022 totaled $51,844 compared to revenues of $0.5 million for the first quarter of 2021. The decrease is primarily due the Company's change in business model and strategy, resulting in decreased PrintRite3D® unit sales, and partially offset by an increase in revenue from its subscription-based pricing program.
Gross profit for the first quarter of 2022 was $11,785, which resulted in a gross margin of 23% as compared to $0.3 million, or 72% in the first quarter of 2021.
Total operating expenses for the first quarter of 2022 were $2.3 million as compared to total operating expenses of $1.8 million for the same period in 2021. The increase in operating expenses was mainly attributable to additional employee headcount, R&D expenses, and organizational costs.
Cash used in operating activities for the three months ended March 31, 2022, totaled $2.0 million compared to $1.2 million in the first quarter of 2021, an increase of $0.8 million.
Net loss for the first quarter of 2022 was $2.2 million, or $0.21 per share, as compared to a net loss of $0.7 million, or $0.09 per share, in the first quarter of 2021.
Cash totaled $9.3 million at March 31, 2022, as compared to $11.4 million at December 31, 2021.
First Quarter 2022 Results Conference Call
Sigma Labs Chairman Mark Ruport, CEO Jacob Brunsberg, and CFO Frank Orzechowski will host the conference call, followed by a question-and-answer period.
To access the call, please use the following information:
Date: | Tuesday April 26, 2022 |
Time: | 4:30 p.m. Eastern time, 1:30 p.m. Pacific time |
Toll-free dial-in number: | 1-877-407-9039 |
International dial-in number: | 1-201-689-8470 |
Conference ID: | 13728947 |
Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact MZ Group at 1-949-491-8235.
The conference call will be broadcast live and available for replay at https://viavid.webcasts.com/starthere.jsp?ei=1542918&tp_key=8fae7f8871 and via the investor relations section of the Company's website at www.sigmalabsinc.com.
A replay of the conference call will be available after 7:30 p.m. Eastern time through May 10, 2022.
Toll-free replay number: | 1-844-512-2921 |
International replay number: | 1-412-317-6671 |
Replay ID: | 13728947 |
About Sigma Labs
Sigma Labs Inc. is a leading provider of in-process quality assurance (IPQA™) software to the additive manufacturing industry. Sigma Labs specializes in the development and commercialization of real-time monitoring and analytics solutions known as PrintRite3D® for 3D metal and polymer advanced manufacturing technologies. PrintRite3D detects and classifies defects and anomalies real-time during the manufacturing process, enabling significant cost-savings and production efficiencies. Sigma Labs believes its software product will be a major catalyst for the acceleration and adoption of industrial 3D printing. For more information, please visit www.sigmalabsinc.com.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words "believe," "anticipate," "estimate," "expect," "intend," "plan," "project," "prospects," "outlook," and similar words or expressions, or future or conditional verbs such as "will," "should," "would," "may," and "could" are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are risks relating to, among other things, market and other conditions, Sigma Labs' business and financial condition, the extent of the market's acceptance of PrintRite3D, Sigma Labs' new monthly subscription pricing model, and of Sigma Labs' business relationships with companies such as Aconity3D and Materialise, and the Company's ability to develop new business relationships with OEMs, the ability of 3D metal printing to move from prototyping to full production, Sigma Labs' ability to satisfy its capital needs through increasing its revenue and obtaining additional financing, and the impact of COVID-19, general economic, industry, political or geopolitical conditions in the United States or internationally. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company's forward-looking statements, please see disclosures contained in Sigma Labs' public filings with the SEC, including the "Risk Factors" in Sigma Labs' Annual Report on Form 10-K, and which may be viewed at www.sec.gov.
Investor Contact:
Chris Tyson
Executive Vice President
MZ Group - MZ North America
949-491-8235
[email protected]
www.mzgroup.us
Company Contact:
Steven Gersten
Sigma Internal IR
813-334-9745
[email protected]
Sigma Labs, Inc.
Condensed Balance Sheets
March 31, 2022 (Unaudited) | December 31, 2021 | |||||||
ASSETS | ||||||||
Current Assets: | ||||||||
Cash | $ | 9,277,929 | $ | 11,447,047 | ||||
Accounts Receivable, net | 261,022 | 412,192 | ||||||
Inventory | 782,099 | 710,080 | ||||||
Prepaid Assets | 165,274 | 114,278 | ||||||
Total Current Assets | 10,486,324 | 12,683,597 | ||||||
Other Assets: | ||||||||
Property and Equipment, net | 288,924 | 232,282 | ||||||
Intangible Assets, net | 978,984 | 925,111 | ||||||
Total Other Assets | 1,267,908 | 1,157,393 | ||||||
TOTAL ASSETS | $ | 11,754,232 | $ | 13,840,990 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
Current Liabilities: | ||||||||
Accounts Payable | $ | 320,547 | $ | 206,442 | ||||
Deferred Revenue | 160,276 | 148,855 | ||||||
Accrued Expenses | 416,643 | 625,942 | ||||||
Total Current Liabilities | 897,466 | 981,239 | ||||||
TOTAL LIABILITIES | 897,466 | 981,239 | ||||||
Stockholders' Equity | ||||||||
Preferred Stock, $0.001 par; 10,000,000 shares authorized; 465 shares issued and outstanding, respectively | 1 | 1 | ||||||
Common Stock, $0.001 par; 24,000,000 shares authorized; 10,498,802 shares issued and outstanding, respectively | 10,499 | 10,499 | ||||||
Additional Paid-In Capital | 53,661,061 | 53,442,431 | ||||||
Accumulated Deficit | (42,814,795 | ) | (40,593,180 | ) | ||||
Total Stockholders' Equity | 10,856,766 | 12,859,751 | ||||||
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ | 11,754,232 | $ | 13,840,990 | ||||
Sigma Labs, Inc.
Condensed Statements of Operations
(Unaudited)
| Three Months Ended | ||||||||
| March 31, 2022 | March 31, 2021 | |||||||
REVENUES | $ | 51,844 | $ | 458,140 | ||||
COST OF REVENUE | 40,091 | 128,331 | ||||||
GROSS PROFIT | 11,753 | 329,809 | ||||||
OPERATING EXPENSES: | ||||||||
Salaries & Benefits | 1,292,010 | 847,171 | ||||||
Stock-Based Compensation | 170,976 | 117,477 | ||||||
Operations and R&D Costs | 143,418 | 196,340 | ||||||
Investor & Public Relations | 94,326 | 108,341 | ||||||
Organization Costs | 58,749 | 77,616 | ||||||
Legal & Professional Service Fees | 211,416 | 176,847 | ||||||
Office Expenses | 205,432 | 148,225 | ||||||
Depreciation & Amortization | 31,584 | 23,031 | ||||||
Other Operating Expenses | 87,787 | 86,356 | ||||||
Total Operating Expenses | 2,295,698 | 1,781,404 | ||||||
LOSS FROM OPERATIONS | (2,283,945 | ) | (1,451,595 | ) | ||||
OTHER INCOME (EXPENSE) | ||||||||
Interest Income | 1,571 | 55 | ||||||
Gain on Derivative Liability | - | 802,285 | ||||||
State Incentives | 76,628 | - | ||||||
Exchange Rate Loss | (330 | ) | (51 | ) | ||||
Interest Expense | (1,319 | ) | (1,353 | ) | ||||
Total Other Income (Expense) | 76,550 | 800,936 | ||||||
LOSS BEFORE PROVISION FOR INCOME TAXES | (2,207,395 | ) | (650,659 | ) | ||||
Provision for Income Taxes | - | - | ||||||
Net Loss | $ | (2,207,395 | ) | $ | (650,659 | ) | ||
Preferred Dividends | (14,220 | ) | (60,908 | ) | ||||
Net Loss Applicable to Common Stockholders | $ | (2,221,615 | ) | $ | (711,567 | ) | ||
Net Loss per Common Share - Basic and Diluted | $ | (0.21 | ) | $ | (0.09 | ) | ||
Weighted Average Number of Shares Outstanding - Basic and Diluted | 10,498,802 | 7,790,121 | ||||||
Sigma Labs, Inc.
Condensed Statements of Cash Flows
(Unaudited)
| March 31, 2022 | March 31, 2021 | |||||||
OPERATING ACTIVITIES | ||||||||
Net Loss | $ | (2,207,395 | ) | $ | (650,659 | ) | ||
Adjustments to reconcile Net Loss to Net Cash used in operating activities: | ||||||||
Noncash Expenses: | ||||||||
Depreciation and Amortization | 31,584 | 23,031 | ||||||
Gain on Derivative Liability | - | (802,285 | ) | |||||
Stock Based Compensation Employees | 170,976 | 117,477 | ||||||
Stock Based Compensation - Third Party Services | 11,713 | 30,981 | ||||||
Stock Based Compensation - Directors | 21,721 | 61,471 | ||||||
Change in assets and liabilities: | ||||||||
Accounts Receivable | 151,170 | (56,488 | ) | |||||
Inventory | (72,019 | ) | (88,129 | ) | ||||
Prepaid Assets | (50,996 | ) | (44,718 | ) | ||||
Accounts Payable | 114,105 | 151,500 | ||||||
Deferred Revenue | 11,421 | (1,540 | ) | |||||
Accrued Expenses | (209,299 | ) | 18,773 | |||||
NET CASH USED IN OPERATING ACTIVITIES | (2,027,019 | ) | (1,240,586 | ) | ||||
INVESTING ACTIVITIES | ||||||||
Purchase of Property and Equipment | (83,248 | ) | (5,350 | ) | ||||
Purchase of Intangible Assets | (58,851 | ) | (16,619 | ) | ||||
NET CASH USED IN INVESTING ACTIVITIES | (142,099 | ) | (21,969 | ) | ||||
FINANCING ACTIVITIES | ||||||||
Gross Proceeds from Public and Private Issuances of Securities | - | 14,869,899 | ||||||
Less Offering Costs | - | (1,600,967 | ) | |||||
Proceeds from Exercise of Warrants | - | 1,136,010 | ||||||
NET CASH PROVIDED BY FINANCING ACTIVITIES | - | 14,404,942 | ||||||
NET CHANGE IN CASH FOR PERIOD | (2,169,118 | ) | 13,142,387 | |||||
CASH AT BEGINNING OF PERIOD | 11,447,047 | 3,700,814 | ||||||
CASH AT END OF PERIOD | $ | 9,277,929 | $ | 16,843,201 | ||||
Supplemental Disclosures: | ||||||||
Noncash investing and financing activities disclosure: | ||||||||
Issuance of Common Shares for Preferred Dividends | 14,220 | 60,908 | ||||||
Other noncash operating activities disclosure: | ||||||||
Issuance of Securities for Services | 33,434 | 92,452 | ||||||
Disclosure of cash paid for: | ||||||||
Interest | $ | 1,319 | $ | 1,353 | ||||
Income Taxes | $ | - | $ | - | ||||
SOURCE: Sigma Labs, Inc.
View source version on accesswire.com:
https://www.accesswire.com/698935/Sigma-Labs-Reports-First-Quarter-2022-Financial-Results